Biomarkers for Cancer Diagnosis

A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to presence of cancer. Genetic, epigenetic, proteomic, glycolic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. While some cancer biomarkers can be used to predict how aggressively your cancer will grow, and are therefore useful for assessing your prognosis, the most promising use of biomarkers today is to identify which therapies a patient’s cancer may or may not respond to.


    Related Conference of Biomarkers for Cancer Diagnosis

    August 27-28, 2026

    22nd Global Biomarkers and Clinical Research Summit

    Paris, France
    September 14-15, 2026

    7th Global Summit on Digital Therapeutics

    Barcelona, Spain
    September 28-29, 2026

    13th International Conference on Stroke and Neurological Disorders

    Amsterdam, Netherlands
    October 19-20, 2026

    6th Euro-Global Summit on Probiotics & Nutraceuticals

    Paris, France
    November 16-17, 2026

    11th Global Summit on Midwifery and Womens Health

    Tokyo, Japan
    December 16-17, 2026

    7th Global Summit on Public Health

    Amsterdam, Netherlands
    January 18-19, 2027

    10th World Congress on PCOS and Reproductive Healthcare

    Bangkok, Thailand
    January 18-19, 2027

    44th International Conference on Women's Health

    Bangkok, Thailand
    February 01-02, 2027

    9th International Conference on Digital Health

    London, UK

    Biomarkers for Cancer Diagnosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in